About this trial

This is a multicenter, prospective, observational, post-market clinical follow-up (PMCF) study designed to evaluate the safety and clinical performance of the Tipmed™ Primary Hip Prosthesis System in adult subjects undergoing primary hip arthroplasty. The study aims to gather real-world clinical evidence on the 24-month post-operative safety profile, potential complications, and functional outcomes of the device during routine clinical practice.

Eligibility criteria

Qualifiers

Individuals aged 18 years and older,

Male or female participants,

Subjects who have undergone Primary Hip Arthroplasty (either total or partial) for any indication,

Subjects in whose surgical procedure the Tipmed™ Primary Hip Prosthesis System components were utilized.

Disqualifiers

Subjects currently participating in any other interventional clinical trial.

Trial design

Treatments tested in this trial

  • Tipmed™ Primary Hip Prosthesis System

Treatment groups

101 Participants
are divided into 1 treatment group

Locations

4
Republic of Turkey Ministry of Health, Balıkesir Provincial Health Directorate, Atatürk City Hospital10100, Balıkesir Turkey (Türkiye)
Republic of Turkey Ministry of Health, Balıkesir Provincial Health Directorate, Burhaniye State Hospital10700, Balıkesir Turkey (Türkiye)
Dokuz Eylül University Research and Application Hospital35330, Izmir Turkey (Türkiye)
Republic of Turkey Ministry of Health Izmir Provincial Health Directorate Izmir Democracy University Buca Seyfi Demirsoy Training and Research Hospital35390, Izmir Turkey (Türkiye)

Sponsors and collaborators

TIPMED Medical Device Manufacturing Ltd. Co.

Lead sponsor